Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), ...
May 28, 2025
0
36
A first-of-its-kind clinical trial shows that therapeutic plasma exchange (TPE) combined with intravenous immunoglobulin reduced biological age on average by 2.6 years, as measured by multi-omic biomarkers. Results of the ...
May 28, 2025
0
0
Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience ...
May 28, 2025
0
0
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the treatment of plaque psoriasis of the scalp and body in adult and pediatric patients 12 years of age ...
May 28, 2025
0
0
Every day, nearly 100 children present to Australian emergency departments with suspected medicine poisoning. It's a startling statistic, but a reality that could be avoided, according to new research from the University ...
May 28, 2025
0
0
Maintenance therapy with lurbinectedin (lurbi) and atezolizumab (atezo) helps some patients with extensive-stage small cell lung cancer (ES-SCLC) live longer versus maintenance therapy with atezolizumab alone, according to ...
May 27, 2025
0
0
The U.S. Food and Drug Administration has approved GSK's Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).
May 26, 2025
0
4
A new study from UNC School of Medicine researchers, published this week in Blood, provides fresh insight into how the body forms and dissolves blood clots—and may help reshape how doctors treat patients at risk of bleeding.
May 26, 2025
0
2
